Search Results - "Lledó, José L."

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli by Fernando, Joan, Sancho, Patricia, Fernández-Rodriguez, Conrado M., Lledó, José L., Caja, Laia, Campbell, Jean S., Fausto, Nelson, Fabregat, Isabel

“…Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma (HCC). The mechanism underlying this effect is not completely understood…”
Get full text

Factors influencing the rate of fibrosis progression in chronic hepatitis C by FERNANDEZ-RODRIGUEZ, Conrado M, GUTIERREZ, Maria Luisa, LOPEZ SERRANO, Pilar, LLEDO, José L, SANTANDER, Cecilio, PEREZ FERNANDEZ, Teresa, TOMAS, Esperanza, CACHO, Guillermo, NEVADO, Manuel, CASAS, Maria Luisa

“…Alcohol consumption, age at infection, and male gender have been identified as risk factors for faster fibrosis progression in patients with chronic hepatitis…”
Get full text

International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis by Díaz‐González, Álvaro, Sanduzzi‐Zamparelli, Marco, Fonseca, Leonardo G., Di Costanzo, Giovan G., Alves, Rogerio, Iavarone, Massimo, Leal, Cassia, Sacco, Rodolfo, Matilla, Ana M., Hernández‐Guerra, Manuel, Aballay Soteras, Gabriel, Wörns, Marcus‐Alexander, Pinter, Matthias, Varela, María, Ladekarl, Morten, Chagas, Aline L., Mínguez, Beatriz, Arenas, Juan I., Granito, Alessandro, Sánchez‐Torrijos, Yolanda, Rojas, Ángela, Rodríguez de Lope, Carlos, Alvares‐da‐Silva, Mario R., Pascual, Sonia, Rimassa, Lorenza, Lledó, José L., Huertas, Carlos, Sangro, Bruno, Giannini, Edoardo G., Delgado, Manuel, Vergara, Mercedes, Perelló, Christie, Lue, Alberto, Sala, Margarita, Gallego, Adolfo, Coll, Susanna, Hernáez, Tania, Piñero, Federico, Pereira, Gustavo, França, Alex, Marín, Juan, Anders, Margarita, Mello, Vivianne, Lozano, Mar, Nault, Jean C., Menéndez, Josemaría, García Juárez, Ignacio, Bruix, Jordi, Reig, María

“…Background & Aims Information on safety and efficacy of systemic treatment in patients with hepatocellular carcinoma (HCC) under dialysis are limited due to…”
Get full text

Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis by Fernández-Rodriguez, Conrado M., Romero, Julian, Petros, Timothy J., Bradshaw, Heather, Gasalla, José M., Luisa Gutiérrez, Maria, Lledó, José L., Santander, Cecilio, Pérez Fernández, Teresa, Tomás, Esperanza, Cacho, Guillermo, Michael Walker, J.

“…: Background: Endocannabinoids may participate in the homeostasis of arterial pressure. Recently, anandamide, the most extensively studied endocannabinoid, has…”
Get full text

Disturbed synthesis of insulinlike growth factor I and its binding proteins may influence renal function changes in liver cirrhosis by FERNANDEZ-RODRIGUEZ, Conrado M, PRADA, Ignacio, ANDRADE, Amalia, MOREIRAS, Mercedes, GUITIAN, Ramon, ALLER, Rocio, LLEDO, José L, CACHO, Guillermo, QUIROGA, Jorge, PRIETO, Jesus

“…Insulinlike growth factor-1 (IGF-1) is an anabolic hormone synthesized by the liver upon stimulation by growth hormone (GH). IGF-1 exerts important effects on…”
Get full text

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli by Fernando, Joan, Sancho, Patrícia, Fernández Rodríguez, Conrado M, Lledó, José L, Caja Puigsubirà, Laia, Campbell, Jean S, Fausto, Nelson, Fabregat Romero, Isabel

“…Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma (HCC). The mechanism underlying this effect is not completely understood…”
Get full text

Transarterial chemoembolisation in intermediate-stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region by Peña, Ana Matilla, Núñez-Martínez, Óscar, Díaz-Sánchez, Antonio, Pons-Renedo, Fernando, Gómez-Rubio, Mariano, Polo-Lorduy, Benjamín, Lledó-Navarro, José L, Trapero-Marugán, María, Ladero-Quesada, José María, Poves-Martínez, Elvira, Ibáñez-Pinto, Alberto, Martín-Algívez, Ana María, Lozano-Maya, Mar, González-Alonso, Raquel, Piqueras-Alcol, Belén, González-Moreno, Leticia, Fernández-Rodríguez, Conrado, Gea-Rodríguez, Francisco

“…AbstractBackground. Transarterial chemoembolisation (TACE), having demonstrated survival benefits, is the treatment of choice in intermediate-stage…”
Get full text